ClinicalTrials.Veeva

Menu

The Trusculpt (Radio Frequency) Device For Thigh Circumference Reduction

Cutera logo

Cutera

Status

Completed

Conditions

Body Fat

Treatments

Device: Trusculpt (Radio Frequency) Device

Study type

Interventional

Funder types

Industry

Identifiers

NCT01665118
C-12-TS05

Details and patient eligibility

About

The objective of this study is to evaluate the safety and efficacy of the Trusculpt (Radio Frequency) device in the reduction of thigh circumference.

Full description

The primary efficacy variable for this study is the comparison of mean change in thigh circumference from baseline to 12 weeks between two arms. The primary research hypothesis is that the mean change in thigh circumference is ≥ 1 cm (indicating mean reduction).

Enrollment

44 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Female
  • Minimum age of 18 years
  • Non-smoking for at least 3 months and willing to refrain from smoking for the duration of the study.
  • Post-menopausal, or on birth control and/or no plans to become pregnant for the duration of the study.
  • Body Mass Index (BMI) ≤ 30
  • Visible fat in the thigh / saddlebag area to be treated
  • Subject must be able to read, understand and sign the Consent Form
  • Subject must adhere to the follow-up schedule and study instructions
  • Subject must adhere to the same diet and/or exercise routine throughout the study, and agree to maintain the same weight throughout the study (within 6 lbs of the weight measure at the baseline assessment)

Exclusion criteria

  • Taking weight-loss medications/supplements
  • Simultaneous participation in any other clinical study
  • Prior surgical treatment to the target area, e.g., liposuction or abdominoplasty
  • Prior treatment to the target area within the last 12 months e.g., radio frequency or cryolysis
  • Arteriosclerosis or weakened blood vessels
  • Heart disease
  • Thromboembolic disease
  • Diagnosed or documented immune system disorders (including Panniculitis)
  • Bleeding disorders
  • Presence of uncontrolled hypertension
  • Taking prescription anticoagulants
  • History of keloid formation
  • History of malignant tumors in the target area
  • Diabetes
  • Any disease or condition that could impair wound healing
  • Skin abnormalities in the target area, e.g., cuts, scrapes, wounds, scars, large moles
  • Infection in the target area
  • Implanted electrical device(s) or metallic implants
  • Pregnant or lactating

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

44 participants in 2 patient groups

Treated Thigh
Experimental group
Description:
Trusculpt (Radio Frequency) Device
Treatment:
Device: Trusculpt (Radio Frequency) Device
Untreated Contra-lateral Thigh
No Intervention group
Description:
To be used as the self control in this split body study.

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems